Clinical trial
Preliminary Efficacy and Tolerability of NCX-1000 After Repeated Oral Doses in…
NCT00414869 · Forest Laboratories, Industry · Terminated
Key facts
| NCT number | NCT00414869 |
|---|---|
| Title | Preliminary Efficacy and Tolerability of NCX-1000 After Repeated Oral Doses in Patients With Elevated Portal Pressure |
| Official title | Preliminary Efficacy And Tolerability Of Oral NCX-1000 After Repeated Administrations In Patients With Portal Hypertension: A Double-Blind Dose Escalating Study |
| Lead sponsor | Forest Laboratories, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Portal Hypertension |
| Intervention type | Drug |
| Interventions | NCX-1000, Placebo |
| Enrollment | 11 |
| Start date | Nov 1, 2005 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Dec 22, 2006 |
| Last update posted | Feb 9, 2017 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: